ALT 0.00% 0.1¢ analytica limited

wiseowl research - 7.6c buy recommendation, page-49

  1. 1,472 Posts.
    jtaylor1 the bloke you are poking has a red heart against his name. That trumps you. he got it because he is regarded as a top class knowledgeable poster. In short he is not an idiot and there is no shortage of those around. But if what you are saying is true, suggest you ring this crowd and tell them to remove the following from their ASX releases.
    I see a lot of low risk not much high risk. damn good of you to pop in though.

    Auto Start Infusion System -

    Appointed first distributor in Taiwan

    PeriCoach -

    Has No Comparable Competition:

    Massive, currently unmet, low risk market.

    Championed by Key Opinion Leaders in the
    incontinence field

    Low cost model

    single SKU for the entire globe, lean distribution direct to consumers worldwide

    Production tooling complete for validation production in October

    Production volumes will be ready for sales in Mid 2014

    ANZ, Europe, USA, with relatively easy regulatory approvals required
 
watchlist Created with Sketch. Add ALT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.